Rock Creek Group LLC boosted its position in Versigent (NYSE:VGNT – Free Report) by 67.2% in the 3rd quarter, HoldingsChannel reports. The firm owned 33,435 shares of the company’s stock after acquiring an additional 13,435 shares during the period. Rock Creek Group LLC’s holdings in Versigent were worth $1,503,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Fortitude Family Office LLC increased its position in Versigent by 497.1% during the third quarter. Fortitude Family Office LLC now owns 621 shares of the company’s stock worth $28,000 after buying an additional 517 shares during the last quarter. Salomon & Ludwin LLC raised its stake in Versigent by 78.3% in the third quarter. Salomon & Ludwin LLC now owns 708 shares of the company’s stock valued at $32,000 after buying an additional 311 shares during the period. Jacobi Capital Management LLC bought a new stake in Versigent in the third quarter valued at approximately $38,000. Farther Finance Advisors LLC raised its stake in Versigent by 53.1% in the third quarter. Farther Finance Advisors LLC now owns 1,052 shares of the company’s stock valued at $47,000 after buying an additional 365 shares during the period. Finally, Signaturefd LLC lifted its position in shares of Versigent by 40.0% in the third quarter. Signaturefd LLC now owns 1,121 shares of the company’s stock valued at $50,000 after buying an additional 320 shares during the last quarter.
Versigent Stock Performance
VGNT stock traded down $0.34 during mid-day trading on Friday, hitting $42.12. 449,859 shares of the company were exchanged, compared to its average volume of 865,765. The business has a 50 day simple moving average of $44.26 and a 200-day simple moving average of $42.67. The company has a current ratio of 1.43, a quick ratio of 1.11 and a debt-to-equity ratio of 5.69. The stock has a market capitalization of $2.98 billion and a PE ratio of 11.00. Versigent has a 1-year low of $26.34 and a 1-year high of $50.88.
Versigent (NYSE:VGNT – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $1.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.79 by $0.12. Versigent had a return on equity of 88.25% and a net margin of 5.47%. The company had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.42 billion. On average, equities analysts forecast that Versigent will post 7.37 earnings per share for the current year.
Versigent Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Friday, December 4th will be paid a dividend of $0.13 per share. The ex-dividend date is Friday, December 4th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.2%.
Insiders Place Their Bets
In related news, Director Kevin Clark sold 47,761 shares of Versigent stock in a transaction that occurred on Thursday, October 8th. The stock was sold at an average price of $44.36, for a total transaction of $2,118,677.96. Following the completion of the sale, the director directly owned 27,571 shares of the company’s stock, valued at approximately $1,223,049.56. This trade represents a 63.40% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Over the last ninety days, insiders sold 220,000 shares of company stock worth $10,065,848.
Analyst Upgrades and Downgrades
VGNT has been the subject of a number of recent analyst reports. Fox Advisors cut Versigent from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, August 5th. Wells Fargo & Company boosted their target price on Versigent from $48.00 to $56.00 and gave the stock an “overweight” rating in a report on Wednesday, August 5th. Weiss Ratings lowered Versigent from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, November 9th. Royal Bank Of Canada dropped their price target on Versigent from $53.00 to $52.00 and set an “outperform” rating on the stock in a research note on Thursday, November 5th. Finally, Deutsche Bank reaffirmed a “buy” rating and set a $54.00 price target on shares of Versigent in a report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $55.08.
View Our Latest Stock Analysis on Versigent
Versigent Profile
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Featured Articles
- Five stocks we like better than Versigent
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding VGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versigent (NYSE:VGNT – Free Report).
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
